Structures of three (2R,3S)-4-(arylmethyl)-1-(4-pheny1-3-amino-2-hydroxy- butyl)-piperazine derivatives, potential anti-malarial agents

Zeitschrift fur Kristallographie

Volumn 224, Issue 9, 2009, Pages 461-470

  Cunico, Wilson ^a,b   Gomes, Claudia R B ^a   Harrison, William T A ^c   Moreth, Marcele ^a   Wardell, James L ^a   Wardell, Solange M S V ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anti malarial; Crystal structure analysis; Hydrogen bonding; Piperazine derivatives; X ray diffraction

Indexed keywords

EID: 70350153289     PISSN: 00442968     EISSN: None     Source Type: Journal    
DOI: 10.1524/zkri.2009.1161     Document Type: Article

References (24)

1. (a) Cunico, W.; Carvalho, S. A.; Gomes, C. R. B.; Marques, G. H.: Farmacos Antimalarias - Historia e Perspectivas. Rev. Bras. Farm. 89 (2008) 49-55.
2. (b) Greenwood, B. M.; Bojang, K.; Whitty, C. J.; Targett, G. A.: Malaria. Lancet 365 (2005) 1487-1498.
3. Coombs, G. H.; Goldberg, D. E.: Klemba, M.; Berry, C.; Kay, J.; Mottram, J. C.: Aspatic Proteases of PLASMODIUM FAL-CIPARUM and other parasitic protozoa as drug targets. Trends Parasitol. 17 (2001) 532-537.
4. Boss, C.; Richard-Bildstein, S.; Weller, T.; Fischli, W.; Meyer, S.; Binkert, C.: Inhibitors of the Plasmodium Falciparum Parasite Aspartic Protease Plasmepsin II As Potential Antimalarial Agents. Curr. Med. Chem. 10 (2003) 883-907.
5. Guiterrez de Teran, H.; Nervall, M.; Ersmark, K.; Liu, P.; Janka, L. K.; Dunn, B.; Hallberg, A.; Å;qvist, J.: Inhibitor Binding to the Plasmepsin IV Aspartic Protease from Plasmodium Falciparum. Biochemistry 45 (2006) 10529.
6. Dash, C.; Kulkami, A.; Dunn, B.; Rao, M.: Aspartic peptidase inhibitors: implications in drug development. Crit. Rev. Biochem. Mol. Biol. 38 (2003) 89-119.
7. Skinner-Adams, T. S.; McCarthy, J. S.; Gardiner, D. L.; Hilton, P. M.; Andrews, K. T.: Antiretrovirals as Antimalarial Agents. J. Infect. Dis. 190 (2004) 1998-2001.
8. Parikh, S.; Gut, J.; Istvan, E.; Goldberg, D. E.; Havlir, D. V.; Rosenthal, P. J.: Antimalarial Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors. Antimicrob. Agents Chemother. 49 (2005) 2983-2985.
9. Andrews, K. T.; Fairlie, D. P.; Madala, P. K.; Ray, J.; Wyatt, D. M.; Hilton, P. M.; Melville, L. A.; Beattie, L.; Gardioner, D. L.; Reid, R. C.; Stoermer, M. J.; Skinner-Adams, T.; Berry, C.; McCarthy, J. S.: Potencies of Human Immunodeficiency Virus Protease Inhibitors In Vitro against Plasmodium falciparum and In Vivo against Murine Malaria. Antimicrob. Agents Chemother. 50 (2006) 639-648.
10. (a) Noteberg, D.; Hamelink, E.; Hulten, J.; Wahlgren, M.; Vrang, L.; Samuelsson, B.; Hallberg, A.: Design and Synthesis of Plasmepsin I and Plasmepsin II Inhibitors with Activity in Plasmodium falciparum-Infected Cultured Human Erythrocytes. J. Med. Chem. 46 (2003) 734-746.
11. (b) Muthas, D.; Noteberg, D.; Sabnis, Y. A.; Hamelink, E.; Vrang, L.; Samuelsson, B.; Karlen, A.; Hallberg, A.: Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II. Bioorg. Med. Chem. 13 (2005) 5371-5390.
12. (c) Haque, T. S.; Skillman, A. G.; Lee, C. E.; Habashita, H.; Gluzman, I. Y.; Ewing, T. J.; Goldberg, D. E.; Kuntz, I. D.; Ellman, J. A. J. Med. Chem. 42 (1999) 1428-1440.
13. Cunico, W.; Gomes, C. R. B.; Moreth, M.; Manhanini, D. P.; Figueiredo, I. H.; Penido, C.; Henriques, M. G. M. O.; Varotti, F. P.; Krettli, A. U.: Synthesis and Antimalarial Activity of Hydroxyethylpiperazine Derivatives. Eur. J. Med. Chem. 44 (2009) 1363-1368.
14. Cunico, W.; Gomes, C. R. B.; Facchinetti, V.; Moreth, M.; Penido, C.; Henriques, M. G. M. O.; Varotti, F. P.; Krettli, L. G.; Krettli, A. U.; da Silva, F. S.; Caffarena, E. R.; de Magalhaes, C. S.: Synthesis, Antimalarial Evaluation and Molecular Modeling Studies of Hydroxyethylpiperazines, Potential Aspartyl Protease Inhibitors (Part 2). Eur. J. Med. Chem. Doi:10.10116/j.ejmech. 2009.03.041
15. Cunico, W.; Ferreira, M. L. G.; Ferreira, T. G.; Penido, C.; Henriques, M. G. M. O.; Krettli, L. G.; Varotti, F. P.; Krettli, A. U.: Synthesis and Antimalarial Activity of Novel Hydroxyethylamines, Potential Aspartyl Protease Inhibitors. Lett Drug Des. Discov. 3 (2008) 178-181.
16. Spek, A. L.: Single-crystal structure validation with the program PLATON. J. Appl. Crystallogr. 36 (2003) 7-13.
17. Hooft, R. W. W.: COLLECT, data collection software. Nonius BV, Delft, The Netherlands (1998).
18. Otwinowski, Z.; Minor, W.: Processing of X-ray Diffraction Data Collected in Oscillation Mode. Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by Carter Jr, C. W.; Sweet, R. M.: pp. 307-326. New York: Academic Press (1997).
19. APEX2, Bruker AXS Inc., Madison, USA (2004).
20. SAINT, Bruker AXS Inc., Madison, USA (2004).
21. Sheldrick, G. M.: SADABS. Version 2.10. Bruker AXS Inc., Madison, Wisconsin, USA (2004).
22. Farrugia, L. J.: ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface. J. Appl. Crystallogr. 30 (1997) 565.
23. Sheldrick, G. M.: SHELXL-97, Program for crystal structure analysis. University of Göttingen, Germany (1997).
24. Sheldrick, G. M.: SHELXS97. Program for the Solution of Crystal Structures. University of Göttingen, Germany (1997).